Chronic Lyme; diagnostic and therapeutic challenges

Acta Neurologica Scandinavica

Volumn 127, Issue S196, 2013, Pages 38-47

  Ljostad U ^a   Mygland, Å ^a,b  

^a Sørlandet Hospital   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Borrelia; Chronic Lyme; Lyme; Neuroborreliosis

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; DOXYCYCLINE; PENICILLIN G;

ACRODERMATITIS; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID ANALYSIS; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; HUMAN; LYME DISEASE; MENTAL DISEASE; MYELITIS; PLEOCYTOSIS; SEROTYPE; REVIEW;

CHRONIC DISEASE; HUMANS; LYME DISEASE;

EID: 84877135190     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12048     Document Type: Article

References (99)

1. Ljostad U, Skogvoll E, Eikeland R et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 2008;7:690-5.
2. Kruger H, Kohlhepp W, Konig S. Follow-up of antibiotically treated and untreated neuroborreliosis. Acta Neurol Scand 1990;82:59-67.
3. Kruger H, Reuss K, Pulz M et al. Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years. J Neurol 1989;236:322-8.
4. Ljostad U, Henriksen TH. Management of neuroborreliosis in European adult patients. Acta Neurol Scand Suppl 2008;188:22-8.
5. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 2007;49:13-21.
6. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330:229-34.
7. Rosenlund S, Baekgaard N, Menne T. [Acrodermatitis chronica atrophicans can be difficult to diagnose]. Ugeskr Laeger 2011;173:3272-3.
8. Schafers M, Neukirchen S, Toyka KV, Sommer C. Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. J Peripher Nerv Syst 2008;13:81-91.
9. Oksi J, Kalimo H, Marttila RJ et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996;6:2143-54.
10. Miklossy J, Kasas S, Zurn AD, Mccall S, Yu S, Mcgeer PL. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation 2008;5:40.
11. Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol 1998;245:262-72.
12. Stanek G, O'connell S, Cimmino M et al. European union concerted action on risk assessment in lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996;108:741-7.
13. Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-134.
14. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010;17:8-16.
15. Cameron D, Gaito A, Harris N et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2004;2:S1-13.
16. Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol 2007;6:544-52.
17. Strle F, Ruzic-Sabljic E, Cimperman J, Lotric-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 2006;43:704-10.
18. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992;115(Pt 2):399-423.
19. Topakian R, Stieglbauer K, Nussbaumer K, Aichner FT. Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge. Cerebrovasc Dis 2008;26:455-61.
20. Pfister HW, Rupprecht TA. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. Int J Med Microbiol 2006;296(Suppl 40):11-6.
21. Gorson KC, Kolb DA, Marks DS, Hayes MT, Baquis GD. Acute brachial diplegia due to Lyme disease. Neurologist 2011;17:24-7.
22. Elamin M, Alderazi Y, Mullins G, Farrell MA, O'connell S, Counihan TJ. Perineuritis in acute lyme neuroborreliosis. Muscle Nerve 2009;39:851-4.
23. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323:1438-44.
24. Steere AC, Drouin EE, Glickstein LJ. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Clin Infect Dis 2011;52(Suppl 3):259-65.
25. Lelovas P, Dontas I, Bassiakou E, Xanthos T. Cardiac implications of Lyme disease, diagnosis and therapeutic approach. Int J Cardiol 2008;129:15-21.
26. Vegsundvag J, Nordeide J, Reikvam A, Jenum P. Late cardiac manifestation of infection with Borrelia burgdorferi (Lyme disease). BMJ 1993;307:173.
27. Stanek G, Klein J, Bittner R, Glogar D. Borrelia burgdorferi as an etiologic agent in chronic heart failure? Scand J Infect Dis Suppl 1991;77:85-7.
28. Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E. Peripheral neuropathy in acrodermatitis chronica atrophicans - effect of treatment. Acta Neurol Scand 2002;106:253-7.
29. Dicaudo DJ, Su WP, Marshall WF, Malawista SE, Barthold S, Persing DH. Acrodermatitis chronica atrophicans in the United States: clinical and histopathologic features of six cases. Cutis 1994;54:81-4.
30. Holmgren AR, Matteson EL. Lyme myositis. Arthritis Rheum 2006;54:2697-700.
31. Muller-Felber W, Reimers CD, De KJ, Fischer P, Pilz A, Pongratz DE. Myositis in Lyme borreliosis: an immunohistochemical study of seven patients. J Neurol Sci 1993;118:207-12.
32. Mora P, Carta A. Ocular manifestations of Lyme borreliosis in Europe. Int J Med Sci 2009;6:124-5.
33. Cameron DJ. Proof that chronic lyme disease exists. Interdiscip Perspect Infect Dis 2010;2010:876450.
34. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet 2012;379:461-73.
35. Ljostad U, Mygland A. The phenomenon of 'chronic Lyme'; an observational study. Eur J Neurol 2012;19:1128-35.
36. Van Dam AP, Kuiper H, Vos K et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993;17:708-17.
37. Von Stedingk LV, Olsson I, Hanson HS, Asbrink E, Hovmark A. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1995;14:1-5.
38. Jaulhac B, Heller R, Limbach FX et al. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis. J Clin Microbiol 2000;38:1895-900.
39. Eiffert H, Karsten A, Thomssen R, Christen HJ. Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis 1998;30:265-8.
40. Cerar T, Ogrinc K, Cimperman J, Lotric-Furlan S, Strle F, Ruzic-Sabljic E. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 2008;46:3375-9.
41. Lebech AM. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. APMIS Suppl 2002;105:1-40.
42. Molloy PJ, Persing DH, Berardi VP. False-positive results of PCR testing for Lyme disease. Clin Infect Dis 2001;33:412-3.
43. Panelius J, Lahdenne P, Saxen H et al. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J Neurol 2003;250:1318-27.
44. Skarpaas T, Ljostad U, Sobye M, Mygland A. Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis 2007;26:675-7.
45. Tjernberg I, Schon T, Ernerudh J, Wistedt AC, Forsberg P, Eliasson I. C6-peptide serology as diagnostic tool in neuroborreliosis. APMIS 2008;116:393-9.
46. Vermeersch P, Resseler S, Nackers E, Lagrou K. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid. Diagn Microbiol Infect Dis 2009;64:347-9.
47. Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 2004;10:1108-32.
48. Johnson BJ, Robbins KE, Bailey RE et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 1996;174:346-53.
49. Ulvestad E, Kristoffersen EK. [False positive serological test in suspected borreliosis]. Tidsskr Nor Laegeforen 2002;122:88-90.
50. Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol 2006;13:1213-5.
51. Blanc F, Jaulhac B, Fleury M et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 2007;69:953-8.
52. Schmidt C, Plate A, Angele B et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011;76:1051-8.
53. Ljostad U, Mygland A. CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 2007;255:732-7.
54. Stanek G, Fingerle V, Hunfeld KP et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011;17:69-79.
55. Feder HM Jr, Johnson BJ, O'connell S et al. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007;357:1422-30.
56. Baker PJ. Perspectives on "chronic Lyme disease". Am J Med 2008;121:562-4.
57. Ljostad U, Mygland A. The phenomenon of 'chronic Lyme'; an observational study. Eur J Neurol 2012;8:1128-35.
58. Hassett AL, Radvanski DC, Buyske S et al. Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum 2008;59:1742-9.
59. Djukic M, Schmidt-Samoa C, Nau R, Von SN, Eiffert H, Schmidt H. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis - the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic. Eur J Neurol 2011;18:547-55.
60. Steere AC, Taylor E, Mchugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993;269:1812-6.
61. Hsu VM, Patella SJ, Sigal LH. "Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum 1993;36:1493-500.
62. Cottle LE, Mekonnen E, Beadsworth MB, Miller AR, Beeching NJ. Lyme disease in a British referral clinic. QJM 2012;105:537-43.
63. Halperin JJ. Nervous system lyme disease: is there a controversy? Semin Neurol 2011;31:317-24.
64. Vatne A, Mygland A, Ljostad U. Multiple sclerosis in Vest-Agder County, Norway. Acta Neurol Scand 2011;123:396-9.
65. Galbussera A, Tremolizzo L, Isella V et al. Lack of evidence for Borrelia burgdorferi seropositivity in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:308.
66. Qureshi M, Bedlack RS, Cudkowicz ME. Lyme disease serology in amyotrophic lateral sclerosis. Muscle Nerve 2009;40:626-8.
67. Halperin JJ. Lyme disease and the peripheral nervous system. Muscle Nerve 2003;28:133-43.
68. Logigian EL. Peripheral nervous system Lyme borreliosis. Semin Neurol 1997;17:25-30.
69. Kindstrand E, Nilsson BY, Hovmark A et al. Polyneuropathy in late Lyme borreliosis - a clinical, neurophysiological and morphological description. Acta Neurol Scand 2000;101:47-52.
70. Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E. Peripheral neuropathy in acrodermatitis chronica atrophicans - a late Borrelia manifestation. Acta Neurol Scand 1997;95:338-45.
71. Harvey WT, Martz D. Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy. Acta Neurol Scand 2007;115:129-31.
72. Halperin JJ, Kaplan GP, Brazinsky S et al. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 1990;47:586-94.
73. Waisbren BA, Cashman N, Schell RF, Johnson R. Borrelia burgdorferi antibodies and amyotrophic lateral sclerosis. Lancet 1987;2:332-3.
74. ALSUntangled Group. ALSUntangled update 1: investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS. Amyotroph Lateral Scler 2009;10:248-50.
75. Miklossy J, Khalili K, Gern L et al. Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis 2004;6:639-49.
76. Miklossy J. Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 2011;8:90.
77. Wolfe F, Clauw DJ, Fitzcharles MA et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600-10.
78. Eikeland R, Mygland A, Herlofson K, Ljostad U. European neuroborreliosis: quality of life 30 months after treatment. Acta Neurol Scand 2011;124:349-54.
79. Eikeland R, Ljostad U, Mygland A, Herlofson K, Lohaugen GC. European neuroborreliosis: neuropsychological findings 30 months post-treatment. Eur J Neurol 2012;19:480-7.
80. Ljostad U, Mygland A. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol 2010;17:118-23.
81. Krupp LB, Hyman LG, Grimson R et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003;60:1923-30.
82. Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.
83. Fallon BA, Keilp JG, Corbera KM et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008;70:992-1003.
84. Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996;46:619-27.
85. Rupprecht TA, Elstner M, Weil S, Pfister HW. Autoimmune-mediated polyneuropathy triggered by borrelial infection? Muscle Nerve 2008;37:781-5.
86. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9.
87. Treib J, Grauer MT, Haass A, Langenbach J, Holzer G, Woessner R. Chronic fatigue syndrome in patients with Lyme borreliosis. Eur Neurol 2000;43:107-9.
88. Komaroff AL, Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol 2011;31:325-37.
89. Wormser GP, Shapiro ED. Implications of gender in chronic Lyme disease. J Womens Health (Larchmt) 2009;18:831-4.
90. Aggarwal VR, Mcbeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol 2006;35:468-76.
91. Sigal LH, Hassett AL. Contributions of societal and geographical environments to "chronic Lyme disease": the psychopathogenesis and aporology of a new "medically unexplained symptoms" syndrome. Environ Health Perspect 2002;110(Suppl 4):607-11.
92. Fink P, Schroder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 2010;68:415-26.
93. Wyller VB, Eriksen HR, Malterud K. Can sustained arousal explain the Chronic Fatigue Syndrome? Behav Brain Funct 2009;5:10.
94. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis-randomised comparison of ceftriaxone and penicillin. Lancet 1988;1:1191-4.
95. Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994;44:1203-7.
96. Ogrinc K, Logar M, Lotric-Furlan S, Cerar D, Ruzic-Sabljic E, Strle F. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis. Wien Klin Wochenschr 2006;118:696-701.
97. Oksi J, Nikoskelainen J, Hiekkanen H et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 2007;26:571-81.
98. Sigal LH. Musculoskeletal features of Lyme disease: understanding the pathogenesis of clinical findings helps make appropriate therapeutic choices. J Clin Rheumatol 2011;17:256-65.
99. Stanek G, Strle F. Lyme borreliosis: a European perspective on diagnosis and clinical management. Curr Opin Infect Dis 2009;22:450-4.